Literature DB >> 20546280

Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study.

C H Chang1, W Y Shau, Y D Jiang, H Y Li, T J Chang, W H-H Sheu, C F Kwok, L T Ho, L M Chuang.   

Abstract

AIM: To evaluate annual prevalence and incidence of Type 2 diabetes and to examine possible trends among adults in Taiwan.
METHODS: A retrospective nationwide longitudinal study using the Taiwan National Health Insurance Research Database collected during 1999-2004. Adult patients aged > or = 20 years old with prevalent and incident Type 2 diabetes were identified using ICD-9-CM diagnostic codes. Age-specific and age-direct-standardized annual incidence and prevalence were calculated to describe their trends in different gender and age group and compared using Poisson regression.
RESULTS: During the study years, the age-standardized prevalence of Type 2 diabetes increased from 4.7 to 6.5% for men and from 5.3 to 6.6% for women. The increasing trends in prevalence were significant and higher among people aged < 40 and > or = 80 years. The age-standardized incidence rates of Type 2 diabetes per 1000 person-years were approximately 7.6 and remain stable for men, but decreasing from 7.7 to 6.9 for women. However, the incidence increased significantly in younger adults aged < 40 years whose relative incidence (RI with 95% confidence interval) was 1.31 (1.20-1.42) for men and 1.04 (1.01-1.08) for women. The incidence trends for people aged > or = 40 years were decreased for men and women. The differences in incidence trends between age groups and between genders were all statistically significant (all P < 0.001).
CONCLUSIONS: This study demonstrated a substantial increasing trend in Type 2 diabetes prevalence during 1999-2004 among adults in Taiwan. Despite the incidence decreased in older people, young men aged 20-40 years were most susceptible to higher incidence of Type 2 diabetes.

Entities:  

Mesh:

Year:  2010        PMID: 20546280     DOI: 10.1111/j.1464-5491.2010.03007.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  49 in total

1.  Prevalence of Diabetes, Obesity and Dyslipidaemia in Persons within High and Low Income Groups Living in North and South Trinidad.

Authors:  Shivananda B Nayak; Valendrea Rahming; Yudestri Raghunanan; Chandani Raghoonath; Adriel Rahman; Dillon Rajh; Sherry Rambadan; Nandini Ramdass
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972-2007.

Authors:  Marian Abouzeid; Katja Wikström; Markku Peltonen; Jaana Lindström; Katja Borodulin; Ossi Rahkonen; Tiina Laatikainen
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

3.  C-Reactive Protein Gene Variants and Their Serum Levels in Early Adult-onset Type 2 Diabetes Mellitus.

Authors:  Yu-Chuen Huang; Ching-Chu Chen; Tzu-Yuan Wang; Hung Tran The Nguyen; Yung-Hsiang Chen; Chia-Ming Wu; Ya-Wen Chang; Wen-Ling Liao; Fuu-Jen Tsai
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

4.  Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study.

Authors:  Cheng-Wei Chang; Victor C Kok; Ta-Chien Tseng; Jorng-Tzong Horng; Chun-Eng Liu
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Epidemiology of Diabetes Mellitus in Oman: Results from two decades of research.

Authors:  Jawad A Al-Lawati; Prashanth Panduranga; Hala A Al-Shaikh; Magdi Morsi; Nabil Mohsin; Rajiv B Khandekar; Hawra J Al-Lawati; Riad A Bayoumi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

6.  Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis.

Authors:  Yi-Cheng Chang; Pi-Hua Liu; Yun-Chih Tsai; Yen-Feng Chiu; Shyang-Rong Shih; Low-Tone Ho; Wen-Jane Lee; Chieh-Hua Lu; Thomas Quertermous; J David Curb; Wei-Jei Lee; Po-Chu Lee; You-Han He; Jih-I Yeh; Juey-Jen Hwang; Shu-Huei Tsai; Lee-Ming Chuang
Journal:  J Mol Med (Berl)       Date:  2012-04-15       Impact factor: 4.599

7.  Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study.

Authors:  Wen-Hsuan Hou; Kai-Cheng Chang; Chung-Yi Li; Huang-Tz Ou
Journal:  Br J Clin Pharmacol       Date:  2018-06-29       Impact factor: 4.335

8.  Effect of Cycling on Glycaemia, Blood Pressure, and Weight in Young Individuals with Type 2 Diabetes.

Authors:  Ashok Jhingan; Ram Mohan Jhingan
Journal:  J Clin Diagn Res       Date:  2017-07-01

9.  Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011.

Authors:  Lili Huo; Dianna J Magliano; Fanny Rancière; Jessica L Harding; Natalie Nanayakkara; Jonathan E Shaw; Bendix Carstensen
Journal:  Diabetologia       Date:  2018-02-22       Impact factor: 10.122

10.  Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Jyun-Hong Chen; Huang-Tz Ou; Tzu-Chieh Lin; Edward Chia-Cheng Lai; Yea-Huei Yang Kao
Journal:  Int J Clin Pharm       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.